Skip to content

Frontlight ResearchEarly access

Trial site

Royal Lancaster Infirmary (Site 3012)

Lancaster, Lancashire LA1 4RP, United KingdomNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Chronic lymphocytic leukaemia

Closed trials

Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
NCT06136559· Phase 3· Merck Sharp & Dohme LLC· Source
Contact: Toll Free Number

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Royal Lancaster Infirmary (Site 3012): trial site – Frontlight Research